Lundbeck continues to work diligently to resolve the shortage of SABRIL in Canada and will provide an update on the drug shortage website in the coming weeks, including an estimated end date of the shortage.

Last year, Health Canada authorized the exceptional importation and sale of a third-party supply of vigabatrin while Lundbeck’s shortage is ongoing.

More information, including contact information of the distributor, can be found on Health Canada’s List of Drugs for Exceptional Importation and Sale. Note: the generic name (vigabatrin) must be used on the website.”